Discordance in Biomarker Expression in Breast Cancer After Metastasis: Single Center Experience in India

PURPOSE: Biomarker—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) —discordance plays an essential role in the management and prognosis of patients with metastatic breast cancer. Rates of discordance have been previously reported around 12%...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogia, Ajay, Deo, S. V. Suryanarayana, Sharma, Dayanand, Phulia, Rakesh K., Thulkar, Sanjay, Malik, Prabhat S., Mathur, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528736/
https://www.ncbi.nlm.nih.gov/pubmed/30951390
http://dx.doi.org/10.1200/JGO.18.00184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528736/
https://www.ncbi.nlm.nih.gov/pubmed/30951390
http://dx.doi.org/10.1200/JGO.18.00184

Ejemplares similares